Roles of ATM and ATR Kinases in DNA Damage Responses
Roles of ATM and ATR Kinases in DNA Damage Responses
批准号:
6706268
负责人:
ROBERT T ABRAHAM
金额:
$39.65万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-03-01 至 2006-02-28
中文摘要
描述(由申请人提供):
细胞周期检查点是确保有序的细胞周期的信号转导途径。
细胞周期的进展,增殖细胞不试图
复制或分离受损的染色体。最近的研究指出,
P1 3-激酶相关激酶家族的成员ATM和ATR,作为近端
G1、S和G2检查点通路中的信号传导元件。新兴观点
需要ATM功能来引入适当检查站
对电离辐射诱导的DNA双链断裂的反应,而ATR
在紫外线诱导的DNA损伤反应中起主导作用,
以及由药物或内在错误引起的DNA复制应激
与DNA代谢有关。尽管取得了这些进展,
ATR的基本调节和功能仍不清楚,这在很大程度上是由于
缺乏遗传上易处理的ATR缺陷细胞模型系统。
同样,虽然我们的初步研究已经确定了两个重要的
作为ATM/ATR底物的基因组监视蛋白BRCA 1和hRad 17
激酶在DNA损伤的细胞,这些功能的后果,
磷酸化事件尚未定义。该项目将解决这些问题
通过实施以下具体目标解决关键问题:(1)
完成新ATR-/-细胞系的产生,并表征
这些细胞中的检查点信号缺陷,以及(2)为了确定
ATR介导的磷酸化对BRCA 1基因组维持功能的影响,
通过使用两种新描述的BRCA 1功能测定,(3)
确定ATR/ATM依赖性磷酸化对细胞增殖的调节作用。
hRad 17的检查点信号传导功能,以及(4)为了鉴定和功能性地
表征暴露于细胞中的ATR和ATM的新型含SIT-Q底物
遗传毒性压力。
英文摘要
DESCRIPTION (provided by applicant):
Cell-cycle checkpoints are signal transduction pathways that ensure orderly
progression of the cell cycle, and that proliferating cells do not attempt to
replicate or segregate damaged chromosomes. Recent studies have pinpointed two
members of the P1 3-kinase related kinase family, ATM and ATR, as proximal
signaling elements in the G1, S, and G2 checkpoint pathways. The emerging view
is that ATM function is required for the induction of appropriate checkpoint
responses to ionizing radiation-induced DNA double-strand breaks, while ATR
plays dominant roles in the responses to ultraviolet light induced DNA damage,
as well as to DNA replicative stress induced by drugs or intrinsic errors
associated with DNA metabolism. In spite of this progress, the mechanisms
underlying the regulation and function of ATR remain unclear, due in large part
to the lack of a genetically tractable, ATR-deficient cellular model system.
Similarly, although our preliminary studies have identified two important
genome surveillance proteins, BRCA1 and hRad17, as substrates for the ATM/ATR
kinases in DNA-damaged cells, the functional consequences of these
phosphorylation events have not been defined. This project will address these
critical issues through implementation of the following specific aims: (1) To
complete the generation of a novel ATR-/- cell line, and to characterize the
checkpoint signaling defects in these cells, and (2) To determine the impact of
ATR-mediated phosphorylation on the genome maintenance functions of BRCA1,
through the use of two newly described functional assays for BRCA1, (3) To
define the regulatory effects of ATR/ATM-dependent phosphorylation on the
checkpoint signaling functions of hRad17, and (4) To identify and functionally
characterize novel SIT-Q-containing substrates for ATR and ATM in cells exposed
to genotoxic stress.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
KINASE TARGETS IN HYPOXIC CANCER CELLS
-
批准号:6923492
-
项目类别:
-
资助金额:$18.68万
-
财政年份:2005
-
负责人:ROBERT T ABRAHAM
-
依托单位:
Developmental Pilot Project 2
-
批准号:6990460
-
项目类别:
-
资助金额:$4.43万
-
财政年份:2004
-
负责人:ROBERT T ABRAHAM
-
依托单位:
Roles of ATM and ATR Kinases in DNA Damage Responses
-
批准号:6640664
-
项目类别:
-
资助金额:$39.65万
-
财政年份:2002
-
负责人:ROBERT T ABRAHAM
-
依托单位:
NEW TRANSLATION INITIATION INHIBITORS FOR CANCER THERAPY
-
批准号:6650587
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2002
-
负责人:ROBERT T ABRAHAM
-
依托单位:
Roles of ATM and ATR Kinases in DNA Damage Responses
-
批准号:6555197
-
项目类别:
-
资助金额:$39.65万
-
财政年份:2002
-
负责人:ROBERT T ABRAHAM
-
依托单位:
NEW TRANSLATION INITIATION INHIBITORS FOR CANCER THERAPY
-
批准号:6496689
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2001
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CELL CYCLE TARGETS FOR ANTICANCER DRUGS
-
批准号:6300373
-
项目类别:
-
资助金额:$16.56万
-
财政年份:2000
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CELL CYCLE TARGETS FOR ANTICANCER DRUGS
-
批准号:6102644
-
项目类别:
-
资助金额:$16.56万
-
财政年份:1999
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CELL-CYCLE TARGETS FOR ANTICANCER DRUGS
-
批准号:6269456
-
项目类别:
-
资助金额:$15.96万
-
财政年份:1998
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CELLULAR PHARMACOLOGY OF RAPAMYCIN
-
批准号:6124431
-
项目类别:
-
资助金额:$21.11万
-
财政年份:1997
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CELLULAR PHARMACOLOGY OF RAPAMYCIN
-
批准号:2448920
-
项目类别:
-
资助金额:$18.49万
-
财政年份:1997
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CELLULAR PHARMACOLOGY OF RAPAMYCIN
-
批准号:2837767
-
项目类别:
-
资助金额:$20.49万
-
财政年份:1997
-
负责人:ROBERT T ABRAHAM
-
依托单位:
Cellular Pharmacology of Rapamycin
-
批准号:6574185
-
项目类别:
-
资助金额:$33.6万
-
财政年份:1997
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CANCER CENTER SUPPORT GRANT
-
批准号:6768018
-
项目类别:
-
资助金额:$340.0万
-
财政年份:1997
-
负责人:ROBERT T ABRAHAM
-
依托单位:
Cellular Pharmacology of Rapamycin
-
批准号:6712826
-
项目类别:
-
资助金额:$33.6万
-
财政年份:1997
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CELLULAR PHARMACOLOGY OF RAPAMYCIN
-
批准号:6617287
-
项目类别:
-
资助金额:$14.78万
-
财政年份:1997
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CELL-CYCLE TARGETS FOR ANTICANCER DRUGS
-
批准号:6237156
-
项目类别:
-
资助金额:$15.36万
-
财政年份:1997
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CELLULAR PHARMACOLOGY OF RAPAMYCIN
-
批准号:6329001
-
项目类别:
-
资助金额:$6.96万
-
财政年份:1997
-
负责人:ROBERT T ABRAHAM
-
依托单位:
SIGNAL TRANSDUCTION FROM THE T CELL ANTIGEN RECEPTOR
-
批准号:2184688
-
项目类别:
-
资助金额:$19.13万
-
财政年份:1992
-
负责人:ROBERT T ABRAHAM
-
依托单位:
SIGNAL TRANSDUCTION FROM THE T-CELL ANTIGEN RECEPTOR
-
批准号:2184687
-
项目类别:
-
资助金额:$16.29万
-
财政年份:1992
-
负责人:ROBERT T ABRAHAM
-
依托单位:
海外基金